New TB Vaccine successfully completes a small trial

A new vaccine against Tuberculosis has successfully completed an early trial. Developed by Glaxo Smithkline amd Aeras, the M72 vaccine reduced TB rates by more than half. The current vaccine against TB is Bacillus Calmette–Guérin (BCG). Its effectiveness in children is highly variable by area and it appears ineffective for adults. It was introduced in 1921.
The new vaccine could not have come at a more opportune time. Multiple Drug Resistant (MDR) and Extreme Drug Resistant (XDR) strains of TB are becoming a real threat.
I remember going for my BCG a few months before starting school. The Nurse stamped my right shoulder with a six pronged punch, then applied the fluid. I was told to hold my arm level to ensure it got into my body. I still have six white dots where she stamped me. Can’t say I enjoyed the experience.


About autismjungle

I am a Software Test Analyst. Shortly before I turned 21 I was officially diagnosed, although I had long suspected I was autistic. Welcome to my blog
This entry was posted in Anti-antivaccination, Background Data and tagged , , , , , . Bookmark the permalink.